These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26455990)

  • 1. Sustained and expedited resolution of diabetic papillopathy with combined PRP and bevacizumab.
    Chin EK; Almeida DR; Sohn EH
    Can J Ophthalmol; 2015 Oct; 50(5):e88-91. PubMed ID: 26455990
    [No Abstract]   [Full Text] [Related]  

  • 2. Resolution of diabetic papillopathy after a single intravitreal injection of ranibizumab.
    Willerslev A; Munch IC; Larsen M
    Acta Ophthalmol; 2012 Aug; 90(5):e407-9. PubMed ID: 22268957
    [No Abstract]   [Full Text] [Related]  

  • 3. Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial.
    Preti RC; Ramirez LM; Monteiro ML; Carra MK; Pelayes DE; Takahashi WY
    Br J Ophthalmol; 2013 Jul; 97(7):885-9. PubMed ID: 23686001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy.
    Ernst BJ; García-Aguirre G; Oliver SC; Olson JL; Mandava N; Quiroz-Mercado H
    Acta Ophthalmol; 2012 Nov; 90(7):e573-4. PubMed ID: 22405048
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravitreal bevacizumab for diabetic papillopathy.
    Ornek K; Oğurel T
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):217-8. PubMed ID: 20334555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Abo-Elenin M
    Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal anti-vascular endothelial growth factor in early pregnancy and the complex management of advance diabetic retinopathy and maculopathy during pregnancy.
    Sarmad A; Lip PL
    Acta Ophthalmol; 2016 Dec; 94(8):e812-e813. PubMed ID: 27167587
    [No Abstract]   [Full Text] [Related]  

  • 8. Repeated intravitreal bevacizumab injection with and without macular grid photocoagulation for treatment of diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Dabour SA
    Retina; 2013 Sep; 33(8):1623-9. PubMed ID: 23538584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Foveal Neovascularization in a Patient With Type 1 Diabetes.
    Jao K; Northey LC; Essex RW
    JAMA Ophthalmol; 2018 Sep; 136(9):e182584. PubMed ID: 30242368
    [No Abstract]   [Full Text] [Related]  

  • 10. RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Manabe A; Shimada H; Hattori T; Nakashizuka H; Yuzawa M
    Retina; 2015 Sep; 35(9):1800-7. PubMed ID: 25932549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and Therapeutic Challenges.
    Uparkar MP; Kaul S; Manning DR; Mudvari SS
    Retina; 2016 Mar; 36(3):641-4. PubMed ID: 26492386
    [No Abstract]   [Full Text] [Related]  

  • 12. Resolution of diabetic papillopathy with a single intravitreal injection of bevacizumab combined with triamcinolone acetonide.
    Feng J; Qu JF; Jiang YR
    Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2651-2. PubMed ID: 23801191
    [No Abstract]   [Full Text] [Related]  

  • 13. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.
    Michaelides M; Kaines A; Hamilton RD; Fraser-Bell S; Rajendram R; Quhill F; Boos CJ; Xing W; Egan C; Peto T; Bunce C; Leslie RD; Hykin PG
    Ophthalmology; 2010 Jun; 117(6):1078-1086.e2. PubMed ID: 20416952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.
    Rajendram R; Fraser-Bell S; Kaines A; Michaelides M; Hamilton RD; Esposti SD; Peto T; Egan C; Bunce C; Leslie RD; Hykin PG
    Arch Ophthalmol; 2012 Aug; 130(8):972-9. PubMed ID: 22491395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of diabetic retinopathy with intravitreal Ranibizumab.
    Kernt M; Cserhati S; Seidensticker F; Liegl R; Kampik A; Neubauer A; Ulbig MW; Reznicek L
    Diabetes Res Clin Pract; 2013 Apr; 100(1):e11-3. PubMed ID: 23391744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranibizumab for High-Risk Proliferative Diabetic Retinopathy: An Exploratory Randomized Controlled Trial.
    Figueira J; Silva R; Henriques J; Caldeira Rosa P; Laíns I; Melo P; Gonçalves Nunes S; Cunha-Vaz J
    Ophthalmologica; 2016; 235(1):34-41. PubMed ID: 26630400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months.
    Arevalo JF; Lasave AF; Wu L; Diaz-Llopis M; Gallego-Pinazo R; Alezzandrini AA; Berrocal MH;
    Retina; 2013 Feb; 33(2):403-13. PubMed ID: 23222389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
    Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
    Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intravitreal bevacizumab on macular and peripapillary choroidal thickness in injected and fellow eyes of patients with diabetic macular oedema.
    Örnek N; Örnek K; Oğurel T; Timur İE
    Acta Ophthalmol; 2015 Dec; 93(8):e684-6. PubMed ID: 25683321
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study).
    Jorge R; Costa RA; Calucci D; Cintra LP; Scott IU
    Retina; 2006; 26(9):1006-13. PubMed ID: 17151487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.